Market Closed -
Other stock markets
|
After market 03:59:59 pm | |||
27.81 EUR | +0.25% | 27.82 | +0.04% |
Sep. 18 | PHILIPS NV : Jefferies reaffirms its Sell rating | ZD |
Sep. 17 | PHILIPS NV : JP Morgan reaffirms its Neutral rating | ZD |
Fiscal Period: December | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|---|---|
Revenues | 19.48B | 19.54B | 17.16B | 17.83B | 18.17B | |||||
Total Revenues | 19.48B | 19.54B | 17.16B | 17.83B | 18.17B | |||||
Cost of Goods Sold, Total | 10.4B | 10.75B | 9.93B | 10.63B | 10.72B | |||||
Gross Profit | 9.08B | 8.78B | 7.22B | 7.19B | 7.45B | |||||
Selling General & Admin Expenses, Total | 5.14B | 5.11B | 4.72B | 5.29B | 5.15B | |||||
R&D Expenses | 1.64B | 1.78B | 1.7B | 1.97B | 1.89B | |||||
Other Operating Expenses | 8M | 9M | -32M | 20M | -12M | |||||
Other Operating Expenses, Total | 6.79B | 6.9B | 6.4B | 7.28B | 7.03B | |||||
Operating Income | 2.29B | 1.88B | 825M | -85M | 417M | |||||
Interest Expense, Total | -173M | -160M | -152M | -234M | -285M | |||||
Interest And Investment Income | 79M | 17M | 20M | 28M | 48M | |||||
Net Interest Expenses | -94M | -143M | -132M | -206M | -237M | |||||
Income (Loss) On Equity Invest. | 1M | -9M | -4M | -2M | -98M | |||||
Currency Exchange Gains (Loss) | -2M | 3M | - | 9M | -23M | |||||
Other Non Operating Income (Expenses) | -19M | -22M | 5M | -3M | -7M | |||||
EBT, Excl. Unusual Items | 2.17B | 1.71B | 694M | -287M | 52M | |||||
Restructuring Charges | -524M | - | - | -134M | - | |||||
Merger & Related Restructuring Charges | - | -2M | - | - | - | |||||
Impairment of Goodwill | -97M | -144M | -15M | -1.36B | -8M | |||||
Gain (Loss) On Sale Of Investments | 19M | 131M | 95M | 9M | -26M | |||||
Gain (Loss) On Sale Of Assets | 72M | 2M | -56M | 6M | 61M | |||||
Asset Writedown | -92M | - | -55M | - | - | |||||
Legal Settlements | -22M | - | - | -60M | -606M | |||||
Other Unusual Items | - | -209M | -154M | 92M | - | |||||
EBT, Incl. Unusual Items | 1.53B | 1.49B | 509M | -1.73B | -527M | |||||
Income Tax Expense | 337M | 284M | -103M | -113M | -73M | |||||
Earnings From Continuing Operations | 1.19B | 1.2B | 612M | -1.62B | -454M | |||||
Earnings Of Discontinued Operations | -19M | -10M | 2.71B | 13M | -10M | |||||
Net Income to Company | 1.17B | 1.2B | 3.32B | -1.6B | -464M | |||||
Minority Interest | -5M | -8M | -4M | -3M | -2M | |||||
Net Income - (IS) | 1.17B | 1.19B | 3.32B | -1.61B | -466M | |||||
Net Income to Common Incl Extra Items | 1.17B | 1.19B | 3.32B | -1.61B | -466M | |||||
Net Income to Common Excl. Extra Items | 1.19B | 1.2B | 608M | -1.62B | -456M | |||||
Per Share Items | ||||||||||
Net EPS - Basic | 1.2 | 1.24 | 3.48 | -1.73 | -0.5 | |||||
Basic EPS - Continuing Operations | 1.22 | 1.25 | 0.64 | -1.75 | -0.49 | |||||
Basic Weighted Average Shares Outstanding | 971M | 956M | 953M | 929M | 925M | |||||
Net EPS - Diluted | 1.19 | 1.23 | 3.46 | -1.73 | -0.51 | |||||
Diluted EPS - Continuing Operations | 1.21 | 1.24 | 0.64 | -1.75 | -0.5 | |||||
Diluted Weighted Average Shares Outstanding | 981M | 966M | 958M | 929M | 925M | |||||
Normalized Basic EPS | 1.39 | 1.11 | 0.45 | -0.2 | 0.03 | |||||
Normalized Diluted EPS | 1.38 | 1.1 | 0.45 | -0.2 | 0.03 | |||||
Dividend Per Share | - | 0.81 | 0.81 | - | - | |||||
Payout Ratio | 38.82 | 0.08 | 14.52 | -25.62 | -0.43 | |||||
American Depositary Receipts Ratio (ADR) | 1 | 1 | 1 | 1 | 1 | |||||
Supplemental Items | ||||||||||
EBITDA | 2.88B | 2.53B | 1.47B | 669M | 1.13B | |||||
EBITA | 2.57B | 2.14B | 1.09B | 222M | 707M | |||||
EBIT | 2.29B | 1.88B | 825M | -85M | 417M | |||||
EBITDAR | 2.93B | 2.57B | 1.49B | 708M | 1.18B | |||||
Effective Tax Rate - (Ratio) | 22.05 | 19.07 | -20.24 | 6.53 | 13.85 | |||||
Current Domestic Taxes | 26M | - | - | - | - | |||||
Current Foreign Taxes | 297M | - | - | - | - | |||||
Total Current Taxes | 323M | 475M | 298M | 97M | 201M | |||||
Deferred Domestic Taxes | 71M | - | - | - | - | |||||
Deferred Foreign Taxes | -57M | - | - | - | - | |||||
Total Deferred Taxes | 14M | -190M | -401M | -210M | -274M | |||||
Normalized Net Income | 1.35B | 1.06B | 430M | -182M | 30.5M | |||||
Interest on Long-Term Debt | 6M | 6M | 5M | 25M | 27M | |||||
Non-Cash Pension Expense | 56M | 74M | 36M | 49M | 46M | |||||
Supplemental Operating Expense Items | ||||||||||
Advertising Expense | 972M | 920M | 752M | 739M | 700M | |||||
Selling and Marketing Expenses | 4.51B | 4.46B | 4.12B | 4.61B | 4.52B | |||||
General and Administrative Expenses | 607M | 629M | 599M | 671M | 608M | |||||
Research And Development Expense From Footnotes | 2.08B | 2.14B | 1.98B | 2.29B | 2.02B | |||||
Net Rental Expense, Total | 52M | 36M | 19M | 39M | 51M | |||||
Imputed Operating Lease Interest Expense | 14.02M | 7.44M | 3.32M | 9.62M | 14.64M | |||||
Imputed Operating Lease Depreciation | 37.98M | 28.56M | 15.68M | 29.38M | 36.36M | |||||
Stock-Based Comp., Other (Total) | 105M | 121M | 116M | 104M | 97M | |||||
Total Stock-Based Compensation | 105M | 121M | 116M | 104M | 97M |